stocks logo

SGHT

Sight Sciences Inc
$
3.450
0(0.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.450
Open
3.450
VWAP
3.45
Vol
941.00
Mkt Cap
178.37M
Low
3.450
Amount
3.25K
EV/EBITDA(TTM)
--
Total Shares
49.76M
EV
109.19M
EV/OCF(TTM)
--
P/S(TTM)
2.23
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
19.02M
-0.29%
-0.284
+23.4%
17.53M
-13.02%
-0.288
+30.85%
18.18M
-14.92%
-0.272
+8.81%
Estimates Revision
The market is revising Upward the revenue expectations for Sight Sciences, Inc. (SGHT) for FY2025, with the revenue forecasts being adjusted by 2.14% over the past three months. During the same period, the stock price has changed by 12.01%.
Revenue Estimates for FY2025
Revise Upward
up Image
+2.14%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+3.9%
In Past 3 Month
Stock Price
Go Up
up Image
+12.01%
In Past 3 Month
7 Analyst Rating
up Image
7.83% Upside
Wall Street analysts forecast SGHT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGHT is 3.72 USD with a low forecast of 3.00 USD and a high forecast of 4.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
6 Hold
0 Sell
Hold
up Image
7.83% Upside
Current: 3.450
sliders
Low
3.00
Averages
3.72
High
4.00
Morgan Stanley
Equal Weight
maintain
$3 -> $4
2025-07-15
Reason
Morgan Stanley raised the firm's price target on Sight Sciences to $4 from $3 and keeps an Equal Weight rating on the shares. The firm continues to like the MedTech industry setup into Q2 on relative stability in procedure volumes and hospital capital expenditures across the space, the analyst tells investors in a research note.
Piper Sandler
Matt O'Brien
Neutral
maintain
$4
2025-06-19
Reason
Piper Sandler analyst Matt O'Brien raised the firm's price target on Sight Sciences to $4 from $3.50 and keeps a Neutral rating on the shares. The firm notes shares of Sight Sciences have seen some recovery year-to-date, up +10.7% after a challenging 2024 campaign. Piper likes the company's MIGS technology and views the company's dry eye asset as an intriguing product in a large end-market, but it wrestles with uncertainty in the glaucoma business, namely the late '24 LCD reimbursement change and potential trialing of a recent competitor product launch. Further, Piper suspects Sight Sciences will need to access the capital markets in the next 1-2 years, and it thinks it will take dry eye at least several quarters to find its stride with the change in commercial/reimbursement strategy.
Citi
Neutral
maintain
2025-05-22
Reason
Citi raised the firm's price target on Sight Sciences to $3.60 from $3.20 and keeps a Neutral rating on the shares. The firm updated models in medical technology following the Q1 reports. The good news is that underlying sector fundamentals appear intact, including volumes, pricing, and capex, the analyst tells investors in a research note.
Lake Street
Hold
maintain
$3
2025-05-09
Reason
Lake Street raised the firm's price target on Sight Sciences to $3 from $2.50 and keeps a Hold rating on the shares. The firm, which believes Q1 highlights stabilization in the face of MIGS LCD pressures, continues to see potential for reacceleration in 2026 and thinks shares are likely trading near a trough multiple, but also believes broader payer progress on TearCare and normalized MIGS procedure volumes will be required to support growth acceleration.
Needham
David Saxon
Hold
Reiterates
n/a
2025-04-09
Reason
Needham
David Saxon
Hold
Reiterates
n/a
2025-03-06
Reason

Valuation Metrics

The current forward P/E ratio for Sight Sciences Inc (SGHT.O) is -3.24, compared to its 5-year average forward P/E of -7.32. For a more detailed relative valuation and DCF analysis to assess Sight Sciences Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-7.32
Current PE
-3.24
Overvalued PE
-2.70
Undervalued PE
-11.94

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-6.21
Current EV/EBITDA
-2.79
Overvalued EV/EBITDA
0.62
Undervalued EV/EBITDA
-13.04

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
6.16
Current PS
2.47
Overvalued PS
12.13
Undervalued PS
0.18

Financials

Annual
Quarterly
FY2025Q1
YoY :
-9.12%
17.51M
Total Revenue
FY2025Q1
YoY :
-5.87%
-13.86M
Operating Profit
FY2025Q1
YoY :
-12.98%
-14.15M
Net Income after Tax
FY2025Q1
YoY :
-15.15%
-0.28
EPS - Diluted
FY2025Q1
YoY :
+17.19%
-11.61M
Free Cash Flow
FY2025Q1
YoY :
+0.83%
86.21
Gross Profit Margin - %
FY2025Q1
YoY :
-36.83%
-31.29
FCF Margin - %
FY2025Q1
YoY :
-4.25%
-80.84
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
304.5K
USD
6
3-6
Months
147.6K
USD
5
6-9
Months
233.0K
USD
9
0-12
Months
2.8M
USD
10
Bought
0-3
9
1.2M
USD
Months
3-6
2
53.3K
USD
Months
6-9
2
32.4K
USD
Months
0-12
3
2.1M
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
887.9K
Volume
Months
6-9
1
1.4M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

SGHT News & Events

Events Timeline

2025-07-30 (ET)
2025-07-30
07:17:32
Sight Sciences announces results of CUA assessing TearCare system
select
2025-07-29 (ET)
2025-07-29
07:09:41
Sight Sciences announces publication of 24-month results of SAHARA RCT
select
2025-05-08 (ET)
2025-05-08
16:50:35
Sight Sciences has exposure to tariffs imposed by the U.S. on China
select
Sign Up For More Events

News

9.0
07-29Newsfilter
PinnedSight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease
5.0
07-08NASDAQ.COM
Insider Sale: Chief Financial Officer of $SGHT Sells 19,260 Shares
4.0
06-18Benzinga
Piper Sandler Maintains Neutral on Sight Sciences, Raises Price Target to $4
Sign Up For More News

FAQ

arrow icon

What is Sight Sciences Inc (SGHT) stock price today?

The current price of SGHT is 3.45 USD — it has increased 0 % in the last trading day.

arrow icon

What is Sight Sciences Inc (SGHT)'s business?

arrow icon

What is the price predicton of SGHT Stock?

arrow icon

What is Sight Sciences Inc (SGHT)'s revenue for the last quarter?

arrow icon

What is Sight Sciences Inc (SGHT)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Sight Sciences Inc (SGHT)'s fundamentals?

arrow icon

How many employees does Sight Sciences Inc (SGHT). have?

arrow icon

What is Sight Sciences Inc (SGHT) market cap?